Test of EEN to get remission in newly diagnosed UC
Part of Digestive system clinical trials.
This trial studies whether a special nutrition treatment (EEN) can help children with newly diagnosed ulcerative colitis (UC) calm down and reach remission. It’s most likely for children with moderate to severe symptoms at the start, and it avoids people who already had certain medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have newly diagnosed ulcerative colitis (UC)
- Your age is between 6 and 18 years old
- Your UC symptoms at diagnosis were moderate to severe
- Your UC symptoms at diagnosis were not mild
- You have not been treated with corticosteroids (steroid medicines) or biologics before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether transferring healthy stool bacteria into the gut (fecal microbiota transplantation, or FMT) can improve symptoms in children with ulcerative colitis. It may help by changing gut bacteria, especially for children who are newly diagnosed or who didn’t respond to standard treatments.
This trial compares two treatment approaches for children newly diagnosed with ulcerative colitis: starting with stronger medicines right away versus beginning simpler and stepping up if needed. It may help your child learn which strategy controls symptoms better with fewer flare-ups.
This trial tests whether naturopathic approaches—treatments derived from natural sources—can help reduce symptoms in adults with active ulcerative colitis, a condition causing inflammation and ulcers in the colon. The study aims to see if these natural methods can improve your digestive health and quality of life.
This trial tests whether exosomes from milk can help adults with ulcerative colitis. Exosomes are tiny particles that may reduce inflammation in the colon.
This trial tests whether “treat-to-target” care—guided by regular symptom checks, telemonitoring, and patient education—works better than standard follow-up when starting adalimumab for ulcerative colitis. It aims to help control inflammation more effectively and reduce flare-ups.
This trial tests whether a special liquid-only diet (exclusive enteral nutrition) can help people with active Crohn's disease, including those with complications like fistulas or narrowing of the intestine. It aims to improve nutrition and reduce disease activity without medication.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.